Maryland Capital Management Pfizer Inc Transaction History

Maryland Capital Management

$1.2 Billion
Q3 2022

A detailed history of Maryland Capital Management transactions in Pfizer Inc stock. As of the latest transaction made, Maryland Capital Management holds 236,092 shares of PFE stock, worth $6.75 Million. This represents 0.86% of its overall portfolio holdings.

Number of Shares

236,092

Previous 236,139 0.02%

Holding current value

$6.75 Million

Previous $12.4 Million 16.54%

% of portfolio

0.86%

Previous 0.97%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $2,056 - $2,510	-47 Reduced 0.02%	236,092 $10.3 Million
Q2 2022 Aug 11, 2022	BUY	$46.53 - $55.17 $206,127 - $244,403	4,430 Added 1.91%	236,139 $12.4 Million
Q1 2022 May 12, 2022	BUY	$45.75 - $56.69 $1.17 Million - $1.45 Million	25,570 Added 12.4%	231,709 $12 Million
Q4 2021 Feb 11, 2022	BUY	$41.32 - $61.25 $39,006 - $57,820	944 Added 0.46%	206,139 $12.2 Million
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $456,202 - $586,031	-11,623 Reduced 5.36%	205,195 $8.83 Million
Q2 2021 Aug 13, 2021	BUY	$35.91 - $40.68 $237,472 - $269,016	6,613 Added 3.15%	216,818 $8.49 Million
Q1 2021 May 11, 2021	SELL	$33.49 - $37.77 $328,302 - $370,259	-9,803 Reduced 4.46%	210,205 $7.62 Million
Q4 2020 Feb 11, 2021	BUY	$33.47 - $42.56 $516,040 - $656,190	15,418 Added 7.54%	220,008 $8.1 Million
Q3 2020 Nov 12, 2020	BUY	$31.75 - $37.25 $261,175 - $306,418	8,226 Added 4.19%	204,590 $7.51 Million
Q2 2020 Aug 12, 2020	BUY	$30.12 - $36.54 $457,040 - $554,457	15,174 Added 8.37%	196,364 $6.42 Million
Q1 2020 May 13, 2020	BUY	$27.03 - $38.62 $713,646 - $1.02 Million	26,402 Added 17.06%	181,190 $5.91 Million
Q4 2019 Feb 11, 2020	BUY	$32.92 - $37.36 $305,563 - $346,775	9,282 Added 6.38%	154,788 $6.06 Million
Q3 2019 Nov 12, 2019	BUY	$32.49 - $42.13 $218,397 - $283,197	6,722 Added 4.84%	145,506 $5.23 Million
Q2 2019 Aug 13, 2019	BUY	$36.98 - $41.52 $206,496 - $231,847	5,584 Added 4.19%	138,784 $6.01 Million
Q1 2019 May 13, 2019	BUY	$37.5 - $41.2 $580,425 - $637,693	15,478 Added 13.15%	133,200 $5.66 Million
Q4 2018 Feb 13, 2019	BUY	$38.47 - $43.86 $314,069 - $358,073	8,164 Added 7.45%	117,722 $5.14 Million
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $81,590 - $98,964	-2,367 Reduced 2.11%	109,558 $4.83 Million
Q2 2018 Aug 13, 2018	BUY	$32.98 - $35.16 $2,671 - $2,847	81 Added 0.07%	111,925 $4.06 Million
Q1 2018 May 14, 2018	SELL	$31.91 - $37.02 $98,984 - $114,836	-3,102 Reduced 2.7%	111,844 $3.97 Million
Q4 2017 Feb 13, 2018	SELL	$33.26 - $35.29 $95,622 - $101,458	-2,875 Reduced 2.44%	114,946 $4.16 Million
Q3 2017 Nov 14, 2017	SELL	$31.0 - $34.15 $73,501 - $80,969	-2,371 Reduced 1.97%	117,821 $4.21 Million
Q2 2017 Aug 14, 2017	BUY	N/A	120,192	120,192 $4.04 Million

Others Institutions Holding PFE

# of Institutions

3,222

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $160B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Maryland Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Maryland Capital Management with notifications on news.

Account

Maryland Capital Management Pfizer Inc Transaction History